787 844
deoxycytidine in cutaneous melanoma: immunotherapeutic impli-
cations. Clin Cancer Res 2007;13:3333–8.
[33]
Gannon PO, Poisson AO, Delvoye N, Lapointe R, Mes-Masson AM, Saad F. Characterization of the intra-prostatic immune cell infiltra- tion in androgen-deprived prostate cancer patients. J Immunol Methods 2009;348:9–17.[34]
Sorrentino C, Musiani P, Pompa P, Cipollone G, Di Carlo E. Androgen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patients. Clin Cancer Res 2011;17:1571–81.[35]
Trigunaite A, Dimo J, Jorgensen TN. Suppressive effects of andro- gens on the immune system. Cell Immunol 2015;294:87–94.[36]
Drake CG, Sharma P, Gerritsen W. Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy. Oncogene 2014;33:5053–64.
E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 7 7 6 – 7 8 7
787